Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Gemfibrozil Capsules

Approval Number

国药准字H20055225

Company湖北福人福通药业有限公司

Registration Date

June 15, 2021

Previous Approval Numbers

国药准字H20055225

Drug Information

Generic Name

吉非罗齐胶囊

Dosage Form

胶囊剂

Strength

0.3g

Drug Type

化学药品

Registration Date

June 15, 2021

Company Information

Applicant Company

Company Name湖北福人福通药业有限公司

Company Address

湖北咸安经济开发区生物医药产业园兴宁路16号

Manufacturing Company

Company Name湖北福人福通药业有限公司

Company Address

湖北咸安经济开发区生物医药产业园兴宁路16号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy